These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system. Tokman B; Gultekin SE; Sezer C; Alpar R Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668 [TBL] [Abstract][Full Text] [Related]
9. [Correlation study of spontaneous apoptosis, PCNA, and p53 in esophageal squamous-cell carcinoma]. Cheng J; Li C; Shen Z Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):415-7. PubMed ID: 10920931 [TBL] [Abstract][Full Text] [Related]
10. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Sarbia M; Porschen R; Borchard F; Horstmann O; Willers R; Gabbert HE Cancer; 1994 Oct; 74(8):2218-23. PubMed ID: 7922972 [TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase expression causes both the increase of intratumoral microvessels and decrease of apoptosis in human esophageal carcinomas. Okamoto E; Osaki M; Kase S; Adachi H; Kaibara N; Ito H Pathol Int; 2001 Mar; 51(3):158-64. PubMed ID: 11328530 [TBL] [Abstract][Full Text] [Related]
12. Pre-operative radio-chemotherapy enhances apoptotic cell death in oral squamous cell carcinoma. Doi R; Makino T; Adachi H; Ryoke K; Ito H J Oral Pathol Med; 1998 Sep; 27(8):382-7. PubMed ID: 9736427 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas. Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702 [TBL] [Abstract][Full Text] [Related]
14. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer]. Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140 [TBL] [Abstract][Full Text] [Related]
15. Role of p53 gene mutations in human esophageal carcinogenesis: results from immunohistochemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Shi ST; Yang GY; Wang LD; Xue Z; Feng B; Ding W; Xing EP; Yang CS Carcinogenesis; 1999 Apr; 20(4):591-7. PubMed ID: 10223186 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Wang DY; Xiang YY; Tanaka M; Li XR; Li JL; Shen Q; Sugimura H; Kino I Cancer; 1994 Dec; 74(12):3089-96. PubMed ID: 7982172 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas. Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors. Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182 [TBL] [Abstract][Full Text] [Related]
19. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis. Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362 [TBL] [Abstract][Full Text] [Related]